Efeitos da suplementação de óleo de peixe na inflamação subclínica e resistência insulínica em indivíduos com excesso de peso resistentes à insulina
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
Type 2 diabetes (T2D) is a disease of great public health importance due to its
high incidence and mortality rates. The disease is characterized by the inability to maintain
glycemic levels even in the presence of sufficient insulin. The state of subclinical inflammation
observed in overweight individuals is one of the most accepted mechanisms linking obesity and
insulin resistance (IR), making it an important therapeutic intervention pathway in T2D.
Omega-3 fatty acids have anti-inflammatory effects that may contribute to the treatment of
chronic and metabolic diseases. Omega-3 supplementation may help reduce subclinical
inflammation and consequently improve insulin sensitivity in T2D. However, its effects need
to be better clarified. Objective: Thus, the present study aimed to evaluate the effects of omega3-rich fish oil supplementation on markers of subclinical inflammation and insulin resistance
in overweight and insulin-resistant individuals. Methods: The study evaluated the
supplementation of 4g of fish oil (2.4g/day of omega-3) compared to 4g of soybean oil in 24
individuals (equally divided between groups) over 8 weeks. Adults with overweight and insulin
resistance were recruited. The impact of supplementation on inflammatory cytokines (TNFα
and IFNy) and anti-inflammatory cytokines (IL10 and IL4); on IR (Glucose; insulin; HbA1C;
HOMA-IR, and HOMA-β); lipid profile; and lipid peroxidation was assessed. Results: All 24
individuals completed the entire study protocol. Omega-3 supplementation led to a reduction
in IFNy levels after 8 weeks and compared to the control group. A strong, positive (rs2=0.748)
and significant (p=0.005) linear correlation was observed between erythrocyte concentration
and IL10 after 8 weeks of supplementation. No changes were observed in the other markers of
subclinical inflammation, IR, lipid profile, and lipid peroxidation analyzed. Conclusion:
Omega-3 supplementation reduced markers of subclinical inflammation without altering IR in
overweight and insulin-resistant individuals. More studies are needed to evaluate its effects on
different metabolic alterations, particularly those related to T2D.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

